Cargando…

Methylation reactions at dopaminergic nerve endings, serving as biological off-switches in managing dopaminergic functions

Detalles Bibliográficos
Autor principal:	Charlton, Clivel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146098/ https://www.ncbi.nlm.nih.gov/pubmed/25206768 http://dx.doi.org/10.4103/1673-5374.135310

Ejemplares similares

A new mechanism for protection of dopaminergic neurons mediated by astrocytes
por: Segura-Aguilar, Juan
Publicado: (2015)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Application of flavonoids for the protection of nigral dopaminergic neurons from oxidative stress
por: Kim, Sang Ryong
Publicado: (2020)

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
por: Kim, Sang Ryong
Publicado: (2014)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Brain angiotensin II in dopaminergic imbalance-derived pathologies: neuroinflammation and vascular responses
por: Occhieppo, Victoria Belén, et al.
Publicado: (2020)

A dopaminergic switch for fear to safety transitions
por: Luo, Ray, et al.
Publicado: (2018)

Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression
por: Collo, Ginetta, et al.
Publicado: (2018)

The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson's disease
por: Wimalasena, Kandatege
Publicado: (2016)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication
por: Tinkhauser, Gerd, et al.
Publicado: (2017)

Dopaminergic function and intertemporal choice
por: Joutsa, J, et al.
Publicado: (2015)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
por: Mahajani, Sameehan, et al.
Publicado: (2020)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)

Dopaminergic Control of the Exploration-Exploitation Trade-Off via the Basal Ganglia
por: Humphries, Mark D., et al.
Publicado: (2012)

Dopaminergic modulation of the exploration/exploitation trade-off in human decision-making
por: Chakroun, Karima, et al.
Publicado: (2020)

A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system
por: Collo, Ginetta, et al.
Publicado: (2019)

Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System
por: Takeuchi, Hikaru, et al.
Publicado: (2018)

Dopaminergic therapy in aphasia
por: Gill, Sumanjit K., et al.
Publicado: (2013)

Non-Dopaminergic Therapies
por: Nutt, John G., et al.
Publicado: (2018)

The Cerebellar Dopaminergic System
por: Flace, Paolo, et al.
Publicado: (2021)

Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D(2)- muscarinic acetylcholine M(1) receptor heteromer
por: Crans, René A. J., et al.
Publicado: (2020)

RNAi off-targeting: Light at the end of the tunnel
por: Brown, Kirk, et al.
Publicado: (2006)

Changing pattern in the basal ganglia: motor switching under reduced dopaminergic drive
por: Fiore, Vincenzo G., et al.
Publicado: (2016)

Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons
por: Schwartzentruber, Aurelie, et al.
Publicado: (2020)

Dopaminergic Modulation of Orofacial Mechanical Hypersensitivity Induced by Infraorbital Nerve Injury
por: Maegawa, Hiroharu, et al.
Publicado: (2020)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Dopaminergic Modulation of Biological Motion Perception in patients with Parkinson’s disease
por: Liu, Tingting, et al.
Publicado: (2017)

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021)

Deficits in Sustained Attention and Changes in Dopaminergic Protein Levels following Exposure to Proton Radiation Are Related to Basal Dopaminergic Function
por: Davis, Catherine M., et al.
Publicado: (2015)

Disinhibition Bursting of Dopaminergic Neurons
por: Lobb, Collin J., et al.
Publicado: (2011)

Role of dopaminergic system in migraine
por: Cherchi, Alessandra, et al.
Publicado: (2001)

The Dopaminergic System in Autoimmune Diseases
por: Pacheco, Rodrigo, et al.
Publicado: (2014)

Dopaminergic effects on in vitro osteogenesis
por: Lee, Dong Joon, et al.
Publicado: (2015)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019)

Editorial: Dopaminergic Alterations in Schizophrenia
por: Tricklebank, Mark D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62hkikkueua1tuvr2ae8aih5ps